| VAMP4 |
VAMP4: Vesicle-associated membrane protein 4 |
TSNARE1 |
TSNARE1: T-SNARE domain containing 1 |
10.360 |
Evidence |
|
| SAT |
SAT1, SAT: Diamine acetyltransferase 1 |
HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
10.360 |
Evidence |
|
| PROC |
PROC: Vitamin K-dependent protein C precursor |
PSAP |
PSAP, GLBA, SAP1: Proactivator polypeptide precursor [Contains: Saposin-A |
10.360 |
Evidence |
|
| EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
10.350 |
Evidence |
|
| TEC |
TEC, PSCTK4: Tyrosine-protein kinase Tec |
IGFBP7 |
IGFBP7, MAC25, PSF: Insulin-like growth factor-binding protein 7 precursor |
10.350 |
Evidence |
|
| PRLR |
PRLR: Prolactin receptor precursor |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
10.350 |
Evidence |
|
| GHR |
GHR: Growth hormone receptor precursor |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
10.350 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
RYR2 |
RYR2: Ryanodine receptor 2 |
10.350 |
Evidence |
|
| CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
RYR2 |
RYR2: Ryanodine receptor 2 |
10.350 |
Evidence |
|
| CD1A |
CD1A: T-cell surface glycoprotein CD1a precursor |
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
10.350 |
Evidence |
|
| WWOX |
WWOX, FOR, WOX1: WW domain-containing oxidoreductase |
STUB1 |
STUB1, CHIP, PP1131: STIP1 homology and U box-containing protein 1 |
10.340 |
Evidence |
|
| SGK3 |
SGK3, SGK2, SGKL: Serine/threonine-protein kinase Sgk3 |
HSP90AA1 |
Hsp89-alpha-delta-N |
10.340 |
Evidence |
|
| CREBBP |
CREBBP, CBP: CREB-binding protein |
KLF13 |
KLF13, BTEB3, NSLP1: Krueppel-like factor 13 |
10.340 |
Evidence |
|
| MTA1 |
MTA1: Metastasis-associated protein MTA1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
10.340 |
Evidence |
|
| RELA |
RELA, NFKB3: Transcription factor p65 |
RBL2 |
RBL2, RB2: Retinoblastoma-like protein 2 |
10.340 |
Evidence |
|
| MAP3K10 |
MAP3K10, MLK2, MST: Mitogen-activated protein kinase kinase kinase 10 |
KIF3A |
KIF3A, KIF3: Kinesin-like protein KIF3A |
10.340 |
Evidence |
O
|
| H3F3A |
H3F3A, H3.3A, PP781, H3.3B, H3F3B, H3F3: Histone H3.3 |
BARD1 |
BARD1: BRCA1-associated RING domain protein 1 |
10.340 |
Evidence |
|
| HIST1H3A |
HIST1H3A, H3FA, HIST1H3B, H3FL, HIST1H3C, H3FC, HIST1H3D, H3FB, HIST1H3E, H3FD, |
CBX3 |
CBX3: Chromobox protein homolog 3 |
10.340 |
Evidence |
|
| STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
HDAC2 |
HDAC2: Histone deacetylase 2 |
10.340 |
Evidence |
|
| EPS15 |
EPS15, AF1P: Epidermal growth factor receptor substrate 15 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
10.340 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
EPRS |
EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: |
10.340 |
Evidence |
|
| STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
HSP90AA1 |
Hsp89-alpha-delta-N |
10.340 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
HSP90AA1 |
Hsp89-alpha-delta-N |
10.340 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
10.340 |
Evidence |
|
| POLR2A |
POLR2A: Uncharacterized protein POLR2A |
SFRS1 |
SFRS1, ASF, OK/SW-cl.3, SF2, SF2P33: Splicing factor, arginine/serine-rich 1 |
10.340 |
Evidence |
|